POINT Biopharma Global Inc.
DelistedCIK 1811764fmd_0BP1JCDXRZZRWW69R6AS5GS2CBManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | – | 0 | 227 |
| Net interest income | (0) | (0) | 4 |
| Research and development | 9 | 34 | 82 |
| Total operating expenses | 13 | 46 | 101 |
| Operating income | (13) | (46) | 126 |
| Other non-operating income (expense) | (0) | (0) | 4 |
| Income before taxes | (13) | (46) | 130 |
| Income tax expense | 0 | 0 | 31 |
| Net income from continuing operations | (13) | (46) | 98 |
| Net income | (13) | (46) | 98 |